Differential modulation of human intestinal bifidobacterium populations after consumption of a wild blueberry (Vaccinium angustifolium) drink.
- 2013-08-19
- Journal of Agricultural and Food Chemistry 61(34)
- S. Guglielmetti
- D. Fracassetti
- Valentina Taverniti
- C. Del Bo’
- Stefano Vendrame
- D. Klimis-Zacas
- S. Arioli
- P. Riso
- M. Porrini
- PubMed: 23883473
- DOI: 10.1021/jf402495k
Abstract
Bifidobacteria are gaining increasing interest as health-promoting bacteria. Nonetheless, the genus comprises several species, which can exert different effects on human host. Previous studies showed that wild blueberry drink consumption could selectively increase intestinal bifidobacteria, suggesting an important role for the polyphenols and fiber present in wild blueberries. This study evaluated the modulation of the most common and abundant bifidobacterial taxonomic groups inhabiting the human gut in the same fecal samples. The analyses carried out showed that B. adolescentis, B. breve, B. catenulatum/pseudocatelulatum, and B. longum subsp. longum were always present in the group of subjects enrolled, whereas B. bifidum and B. longum subsp. infantis were not. Furthermore, it was found that the most predominant bifidobacterial species were B. longum subsp. longum and B. adolescentis. The results obtained revealed a high interindividual variability; however, a significant increase of B. longum subsp. infantis cell concentration was observed in the feces of volunteers after the wild blueberry drink treatment. This bifidobacterial group was shown to possess immunomodulatory abilities and to relieve symptoms and promote the regression of several gastrointestinal disorders. Thus, an increased cell concentration of B. longum subsp. infantis in the human gut could be considered of potential health benefit. In conclusion, wild blueberry consumption resulted in a specific bifidogenic effect that could positively affect certain populations of bifidobacteria with demonstrated health-promoting properties.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bifidobacterium | Increased Bifidobacterium longum and Bifidobacterium infantis Carriage | Beneficial | Moderate |
Bifidobacterium infantis | Improved Gastrointestinal Health | Beneficial | Moderate |
Bifidobacterium infantis BI02 | Relieved Intestinal Impairments | Beneficial | Moderate |
Bifidobacterium infantis HA-116 | Increased Bifidobacterial Populations | Beneficial | Moderate |
Bifidobacterium infantis HA-116 | Reduced Gastrointestinal Disorder Symptoms | Beneficial | Moderate |
Bifidobacterium infantis MAK22B04I | Relieved Gastrointestinal Symptoms | Beneficial | Moderate |
Bifidobacterium infantis SD-6720 | Reduced Gastrointestinal Disorders | Beneficial | Moderate |
Bifidobacterium infantis SD-6720 | Reduced Gastrointestinal Symptoms | Beneficial | Moderate |
Bifidobacterium infantis VPro 53 | Regression of Gastrointestinal Disorders | Beneficial | Moderate |
Bifidobacterium longum BL03 | Enhanced Immunomodulation | Beneficial | Moderate |
Bifidobacterium longum BL03 | Reduced Gastrointestinal Symptoms | Beneficial | Moderate |
Bifidobacterium longum iVE-15 | Improved Gastrointestinal Health | Beneficial | Moderate |
Bifidobacterium longum Rosell-175 | Relieved Gastrointestinal Symptoms | Beneficial | Moderate |
Bifidobacterium longum SP54 | Improved Immunomodulation | Beneficial | Moderate |
Bifidobacterium longum SP54 | Reduced Gastrointestinal Disorder Symptoms | Beneficial | Moderate |
Bifidobacterium longum subsp. infantis | Relieved Intestinal Impairments | Beneficial | Moderate |
Bifidobacterium longum subsp. infantis M-63 | Improved Immunomodulation | Beneficial | Moderate |
Bifidobacterium longum subsp. infantis M-63 | Relieved Intestinal Impairments | Beneficial | Moderate |
Bifidobacterium longum subsp. longum 35624 | Reduced Gastrointestinal Disorder Symptoms | Beneficial | Moderate |
Bifidobacterium longum UABI-14 | Improved Gastrointestinal Health | Beneficial | Moderate |